Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Sei Investments Co.

Sei Investments Co. lowered its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 222,707 shares of the company’s stock after selling 14,604 shares during the period. Sei Investments Co.’s holdings in Prestige Consumer Healthcare were worth $15,333,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Opal Wealth Advisors LLC acquired a new stake in Prestige Consumer Healthcare during the second quarter worth about $26,000. Quest Partners LLC grew its stake in shares of Prestige Consumer Healthcare by 2,826.7% in the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after buying an additional 424 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the period. Gladius Capital Management LP acquired a new position in Prestige Consumer Healthcare in the second quarter valued at approximately $35,000. Finally, ORG Partners LLC purchased a new position in Prestige Consumer Healthcare in the second quarter worth approximately $39,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Trading Up 0.8 %

NYSE PBH opened at $71.35 on Friday. Prestige Consumer Healthcare Inc. has a one year low of $56.34 and a one year high of $75.80. The firm has a 50 day simple moving average of $71.22 and a 200-day simple moving average of $69.64. The firm has a market cap of $3.54 billion, a price-to-earnings ratio of 17.11, a PEG ratio of 2.04 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. The business had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company’s revenue was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.06 earnings per share. Equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Jefferies Financial Group restated a “hold” rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday. DA Davidson boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.